Here are the top 5 articles for the month of November.
Hi, this is Laura Joszt for The American Journal of Managed Care®. Here are the top 5 articles for the month of November.
Number 5: Data presented at the 2019 American Heart Association Scientific Sessions may have answered how a purified fish oil pill reduces cardiovascular events. The research suggests the pill helps slow the advance of various coronary plaques.
Number 4: At the American Society of Nephrology's Kidney Week 2019 investigators presented data about 3 phase 3 trials of roxadustat. The trials showed promising results about the first-in-class oral drug to treat chronic kidney disease in patients with anemia.
Number 3: First Stop Health’s inaugural 2019 Health Benefits Cost Containment Report found that reigning in benefits spending is a top priority for employers, but many lack the data necessary to make effective changes.
Number 2: Results from ISCHEMIA, presented at the American Heart Association Scientific Sessions, showed invasive procedures like stents are often no better than medical therapy and lifestyle changes at preventing a heart attack in patients with stable heart disease.
Number 1: CMS has launched the process to craft what will come after the Oncology Care Model, the 5-year alternative payment model that ends in 2021. The successor, Oncology Care First, would include a prospective, monthly population payment; accountability for total costs of care incurred over a 6-month episode; changes to make attribution more predictable, and electronic patient-reported outcomes.
To read all of these articles and more, visit ajmc.com.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More